Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Cellebrite Di stock last closed at $10.47, up 0.87% from the previous day, and has increased 87.63% in one year. It has overperformed other stocks in the Software - Infrastructure industry by 0.76 percentage points. Cellebrite Di stock is currently +100.57% from its 52-week low of $5.22, and -16.24% from its 52-week high of $12.50.
At the moment, there are 205.3M CLBT shares outstanding. The market capitalization of CLBT is $2.15B. In the last 24 hours, 503,973 CLBT shares were traded.
You need a brokerage account to access the NASDAQ market and buy CLBT stock.
Based on our research, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountNow that you've picked the best brokerage, you need to fill out some personal details so you are able to buy CLBT today.
Now that you have created your account on investing apps, your next step is to transfer the money for your investment:
Watch this video walkthrough for more details depositing funds into your new brokerage account.
After you have selected the best place to buy Cellebrite Di stock, it's critical to evaluate their stock before you invest, so you can understand the risk as well as the upside.
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on CLBT's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge CLBT's true value.
Using relative valuations ratios:
You can access more valuation analysis on CLBT's stock here.
Out of 5 Equities analysts who monitor CLBT, the consensus analyst rating on CLBT is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Cellebrite Di stock forecast page.
Last year, CLBT revenue was $325.11M. Over the past 4 year, CLBT's revenue has gone up by 17.28% per year. This was faster than the Software - Infrastructure industry average of 16.98%.
Dive into CLBT's earnings and revenue performance here.
Over the last year, executives and large shareholders at CLBT have not bought or sold any shares.
Research more about who owns CLBT shares here.
No, Cellebrite Di doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two primary options:
Press the Open button and eToro will place your order.
If you want more info about buying stocks on eToro, click the helpful video below:
Now that you own some shares in CLBT, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to keep tabs on your CLBT stock.
To reiterate, here are the 6 steps to buy Cellebrite Di stock:
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep an eye on your investment in Cellebrite Di, hit the button below to create your watchlist.